Clinical Research Directory
Browse clinical research sites, groups, and studies.
Population Effectiveness of Dolutegravir Implementation in Sub-Saharan Africa
Sponsor: Massachusetts General Hospital
Summary
This is a prospective observational cohort study enrolling participants in South Africa and Uganda who are prescribed an HIV treatment regimen containing lamivudine, tenofovir, and dolutegravir, which is known as TLD. We hope to better understand how effective TLD will be in sub-Saharan Africa. If treatment failure occurs, we seek to understand the possible reasons, including drug resistance and adherence challenges.
Official title: Population Effectiveness of Dolutegravir Implementation in Sub-Saharan Africa: A Prospective Observational Cohort Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
999
Start Date
2019-05-14
Completion Date
2023-05-31
Last Updated
2026-08-05
Healthy Volunteers
No
Conditions
Interventions
This is an observational study only.
This is an observational study only.
Locations (2)
Africa Health Research Institute
Somkele, KwaZulu-Natal, South Africa
Mbarara University of Science and Technology
Mbarara, Uganda